References
- Shen YC, Chen CF, Chiou WF. Br J Pharmacol 2002; 35: 399–406
- Calabrese C, Berman SH, Babish JG, Ma X, Shinto L, Dorr M, Wells K, Wenner CA, Standish LJ. Phytother Res 2000; 14: 333–338
- Puri A, Saxena R, Saxena RP, Saxena KC, Srivastava V, Tandon JS. J Nat Prod 1993; 56: 995–999
- See D, Mason S, Roshan R. Immunol Invest 2002; 31: 137–153
- Zhang XF, Tan BK. Clin Exp Pharmacol Physiol 2000; 27: 358–363
- Zhang CY, Tan BK. Clin Exp Pharmacol Physiol 2000; 23: 675–678
- Ajaya KR, Sridevi K, Vijaya KN, Nanduri S, Rajagopal S. J Ethnopharmacol 2004; 92: 291–295
- Siripong P, Konckathip B, Preechanukool K, Picha P, Tunsuwan K, Taylor WC. J Sci Soc Thai 1992; 18: 187–194
- Fujita T, Fujitani R, Takeda Y, Takaishi Y, Yamada T, Kido M, Miura I. Chem Pharm Bull 1984; 32(2117)2125
- Matsuda T, Kuroyangagi M, Suguyama S, Umehara K, Ueno A, Nishi K. Chem Pharm Bull 1994; 42: 1216–1225
- Rajagopal S, Ajaya KR, Devi DS, Satyanarayana C, Rajagopalan R. J Expt Ther Oncol 2003; 3: 147–158
- Srinivas N, Vijay NK, Rao TSS, Sridevi K, Kumar PM, Ram PS, Rajagopal S, Kumar RA, Rajagopalan R, Babu JM. Bioorgan Med Chem Lett 2004; 18: 4711–4717
- Boyd MR, Paull KD. Drug Develop Res 1995; 34: 91–109
- Mossman T. J Immunol Meth 1983; 65: 55–63
- Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A. J Natl Cancer Inst 1991; 83: 757–766
- Principles and Practice of Oncology Update, MR Boyd, VT De Vita, Jr, S Hellman, SA Rosenberg, Philadelphia 1989; 1–12
- Weislow OW, Kiser R, Fine D, Bader J, Shoemaker RH, Boyd MR. J Natl Cancer Inst 1989; 81: 577–586